eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Abstracting and indexing Subscription
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2009
vol. 5
 
Share:
Send email
Share:
abstract:

Review paper
Role of cyclooxygenase-2 in cervical cancer

Małgorzata Klimek
,
Krzysztof Urbański
,
Zbigniew Kojs
,
Kazimierz Karolewski
,
Jacek Pudełek
,
Paweł Blecharz

Arch Med Sci 2009; 5, 3: 303-307
Online publish date: 2009/10/22
View full text Get citation
 
Concurrent radiation and chemotherapy is a standard treatment of patients with cervical cancer in FIGO stages IB2-IVA. Chemotherapy given in the same time as irradiation improved survival significant, but not involves all patients. Cancer recurrence is the most common treatment failure in patients with advanced tumor. Further improvement in the treatment of advanced cases is essential. The increasing knowledge about new biologic markers and better ability to predict risk of cancer recurrence is very important for construction of more effective treatment strategies. Currently, there is considerable interest of role of cyclooxgenase-2 in cervical neoplasia. A lot of cancers in different localizations appear to overexpress the cyclooxygenase-2, which may have an important role in carcinogenesis. Ongoing clinical trials, clinical studies have shown the positive therapeutic effect of COX-2 inhibitors and may allow to increase understanding of this novel targeted approach for cervical cancer control.
keywords:

cervical cancer, radiochemotherapy, cyclooxygenase-2
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.